8.3 KETAMINE FOR PEDIATRIC TREATMENT-RESISTANT DEPRESSION: SAFETY, EFFICACY, AND DEVELOPMENTAL CONSIDERATIONS
2021 ◽
Vol 60
(10)
◽
pp. S271
2021 ◽
Vol 60
(10)
◽
pp. S270
2021 ◽
Vol 60
(10)
◽
pp. S270
2020 ◽
Vol 61
(3)
◽
pp. 312-332
◽
2020 ◽
Vol 61
(3)
◽
pp. 333-335
◽